We have shown that the MAMPCs are characterized as CD11b+Ly6ChiLy6G−, expand in the lung with metastatic tumors compared with the normal lung, and suppress CD8+ T cell cytotoxicity in vitro. Here, CD8A is linked to metastatic neoplasm.